Загрузка...
Development of a novel mechanism-based glycolipid adjuvant for vaccination
The inability to elicit strong and durable cellular responses is a major obstacle in the development of successful vaccines, in particular those against malaria. In this regard, the generation of novel adjuvants that will potently boost cell-mediated immunity induced by candidate vaccines is helpful...
Сохранить в:
| Опубликовано в: : | F1000Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
F1000 Research Limited
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5981189/ https://ncbi.nlm.nih.gov/pubmed/29904582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.13794.1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|